Marta Jarlier

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Patient Reported Outcomes

Cross Sectional

Top Venues

Journal for immunotherapy of cancer

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Leticia Aptecar, Frederic Fiteni, Marta Jarlier, Stephanie Delaine, Violaine Guillerme, William Jacot, Veronique D'Hondt
Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients. Breast cancer research and treatment 186 (3) (2021)